FARALLON CAPITAL MANAGEMENT LLC

Q2 2025 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
6/30/2025
Date filed
8/14/2025
Form type
13F-HR
Num holdings
141
Total value ($000)
$23,178,106
Net value change ($000)
+5,242,309 (29.2%)
New positions
21
Sold out positions
15
Turnover %
30.7%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
SPY 3,398,175 NEW
AHC 804,225 NEW
AMZN 665,761 NEW
AKX 350,211 NEW
AON 330,337 87.3%
HIMS 174,415 74.2%
NTRA 171,490 26.7%
AZEK 170,735 NEW
IBIT 158,489 58.4%
BBIO 143,001 72.2%
Top Reduces (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. -403,016 -100.0%
UNH -279,976 -35.7%
SRPT -149,430 -100.0%
MCK -141,294 -38.0%
NYT -129,011 -29.1%
EXEL -125,172 -15.0%
BHVN -115,709 -100.0%
INTU -93,222 -18.1%
SGI -79,415 -100.0%
YMM -75,639 -80.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,869,702 (8.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type